Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stege

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Prostate. Supplement|November 1, 2000
Potential side-effects of endocrine treatment of long duration in prostate cancerR Stege
Acta Chirurgica Scandinavica. Supplementum|January 1, 1980
Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodiesR Stege
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 10, 1993
[Endocrine treatment of prostatic cancer. A renaissance for parenteral estrogen]R Stege, S Sander
British Journal of Urology|March 1, 1997
Testicular and adrenocortical function in men with prostatic cancer and in healthy age-matched controlsK Carlström, R Stege
Urologia Internationalis|January 1, 1990
Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormoneK Carlström, R Stege
International Journal of Technology Assessment in Health Care|January 1, 1991
Cost comparison of parenteral estrogen and conventional hormonal treatment in patients with prostatic cancerP Henriksson, R Stege
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1992
Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasiaR Stege, K Carlström
The Prostate|January 1, 1990
Flutamide has no effect on adrenal androgen response to acute ACTH stimulation in patients with prostatic cancerK Carlström, A Pousette, R Stege
European Journal of Clinical Investigation|December 1, 1996
Profound decrease of in vivo formation of thromboxane during oestrogen therapyP Henriksson, R Stege, K Gréen
Urological Research|January 1, 1989
Androgens during different modes of endocrine treatment of prostatic cancerA Pousette, K Carlström, R Stege
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Prostate. Supplement|November 1, 2000
Potential side-effects of endocrine treatment of long duration in prostate cancerR Stege
Acta Chirurgica Scandinavica. Supplementum|January 1, 1980
Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodiesR Stege
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 10, 1993
[Endocrine treatment of prostatic cancer. A renaissance for parenteral estrogen]R Stege, S Sander
British Journal of Urology|March 1, 1997
Testicular and adrenocortical function in men with prostatic cancer and in healthy age-matched controlsK Carlström, R Stege
Urologia Internationalis|January 1, 1990
Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormoneK Carlström, R Stege
International Journal of Technology Assessment in Health Care|January 1, 1991
Cost comparison of parenteral estrogen and conventional hormonal treatment in patients with prostatic cancerP Henriksson, R Stege
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1992
Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasiaR Stege, K Carlström
The Prostate|January 1, 1990
Flutamide has no effect on adrenal androgen response to acute ACTH stimulation in patients with prostatic cancerK Carlström, A Pousette, R Stege
European Journal of Clinical Investigation|December 1, 1996
Profound decrease of in vivo formation of thromboxane during oestrogen therapyP Henriksson, R Stege, K Gréen
Urological Research|January 1, 1989
Androgens during different modes of endocrine treatment of prostatic cancerA Pousette, K Carlström, R Stege
Pageof 5